DE68926473T2 - Mittel zur Konservierung oder Wiederherstellung der gesunden Haut - Google Patents

Mittel zur Konservierung oder Wiederherstellung der gesunden Haut

Info

Publication number
DE68926473T2
DE68926473T2 DE68926473T DE68926473T DE68926473T2 DE 68926473 T2 DE68926473 T2 DE 68926473T2 DE 68926473 T DE68926473 T DE 68926473T DE 68926473 T DE68926473 T DE 68926473T DE 68926473 T2 DE68926473 T2 DE 68926473T2
Authority
DE
Germany
Prior art keywords
preserving
healthy skin
restoring healthy
chem
restoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68926473T
Other languages
English (en)
Other versions
DE68926473D1 (de
Inventor
Gerard Frans Maria Cauwenbergh
Brabander Marc Joris De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE68926473D1 publication Critical patent/DE68926473D1/de
Application granted granted Critical
Publication of DE68926473T2 publication Critical patent/DE68926473T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Hydrogenated Pyridines (AREA)
DE68926473T 1988-03-28 1989-03-21 Mittel zur Konservierung oder Wiederherstellung der gesunden Haut Expired - Lifetime DE68926473T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17385888A 1988-03-28 1988-03-28

Publications (2)

Publication Number Publication Date
DE68926473D1 DE68926473D1 (de) 1996-06-20
DE68926473T2 true DE68926473T2 (de) 1996-10-02

Family

ID=22633820

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68926473T Expired - Lifetime DE68926473T2 (de) 1988-03-28 1989-03-21 Mittel zur Konservierung oder Wiederherstellung der gesunden Haut

Country Status (15)

Country Link
EP (1) EP0335442B1 (de)
JP (1) JP2747317B2 (de)
KR (1) KR890014089A (de)
AT (1) ATE137964T1 (de)
CA (1) CA1331140C (de)
DE (1) DE68926473T2 (de)
DK (1) DK175695B1 (de)
ES (1) ES2087072T3 (de)
GR (1) GR3019926T3 (de)
IE (1) IE73206B1 (de)
IL (1) IL89749A (de)
NZ (1) NZ228447A (de)
PH (1) PH26635A (de)
PT (1) PT90134B (de)
ZA (1) ZA892231B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703088A (en) * 1989-08-21 1997-12-30 Beth Israel Deaconess Medical Center, Inc. Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5693645A (en) * 1992-12-23 1997-12-02 Beth Israel Deaconess Medical Center, Inc. Use of spiperone or spiperone derivatives as immunosuppressant agents
FR2758263B1 (fr) * 1997-01-16 1999-12-17 Oreal Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
US6150403A (en) * 1997-10-14 2000-11-21 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
DK151811C (da) * 1979-11-23 1988-06-06 Pfizer Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-1-oxo-1h-thiazolooe3,2-aaa-pyrimidin-2-carboxamider eller farmaceutisk acceptable kationsalte deraf samt 1-oxo-1h-thiazolooe3,2-aaapyrimidin-2-carboxylsyrer til anvendelse som udgangsmaterialer ved fremgangsmaaden
JPS56150091A (en) * 1980-03-28 1981-11-20 Janssen Pharmaceutica Nv 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture
US4444780A (en) 1982-08-30 1984-04-24 Ortho Pharmaceutical Corporation Method for treating atopic dermatitis
US4665075A (en) * 1984-12-05 1987-05-12 Janssen Pharmaceutica N.V. Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
JPH07103029B2 (ja) * 1986-09-03 1995-11-08 ライオン株式会社 イソチペンジル類含有組成物
EP0268309B1 (de) * 1986-09-22 1996-12-11 Janssen Pharmaceutica N.V. Serotonin-Antagonisten zur Behandlung von Wunden
JPH0655682A (ja) * 1992-08-06 1994-03-01 Gunze Ltd 熱収縮性多層フィルム

Also Published As

Publication number Publication date
EP0335442A3 (de) 1992-08-12
CA1331140C (en) 1994-08-02
ZA892231B (en) 1990-11-28
DK146589D0 (da) 1989-03-22
EP0335442B1 (de) 1996-05-15
ES2087072T3 (es) 1996-07-16
IE73206B1 (en) 1997-05-07
DE68926473D1 (de) 1996-06-20
NZ228447A (en) 1990-08-28
DK175695B1 (da) 2005-01-24
JPH029808A (ja) 1990-01-12
ATE137964T1 (de) 1996-06-15
PT90134A (pt) 1989-11-10
JP2747317B2 (ja) 1998-05-06
IE890943L (en) 1989-09-28
GR3019926T3 (en) 1996-08-31
KR890014089A (ko) 1989-10-21
EP0335442A2 (de) 1989-10-04
PH26635A (en) 1992-09-04
DK146589A (da) 1989-09-29
PT90134B (pt) 1994-12-30
IL89749A (en) 1993-08-18

Similar Documents

Publication Publication Date Title
DK0634408T3 (da) Depsipeptidderivater, fremstilling og anvendelse deraf
DE3583884D1 (de) Zahnpflegemittel.
DK261490D0 (da) New pharmaceutical compound
ATE109350T1 (de) Verwendung von ofloxacin oder dessen salzen zur herstellung eines lokalpräparats für die behandlung von otopathie.
YU46998B (sh) Postupak za dobijanje derivata cefema i medjuproizvoda za iste
DE68926473T2 (de) Mittel zur Konservierung oder Wiederherstellung der gesunden Haut
DE68912376T2 (de) Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie.
DE69032000T2 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
PT91415A (pt) Processo para a preparacao de novos derivados de furiltiazol
NO903281D0 (no) S-substituerte beta-tioakrylamider og anvendelse derav som mikrobiocider.
ES2064652T3 (es) Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato.
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DE68903019T2 (de) 4,5,6,7-tetrahydroisothiazolo (4,5-c)pyridin-derivate und isomere.
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
NO304921B1 (no) Formulering for behandling eller beskyttelse av et virveldyr mot en parasitt, samt aktiv forbindelse og salt derav
FI840352A0 (fi) Fungicida triazolfoereningar
DE3584426D1 (de) Verwendung von spergualin oder eines seiner pharmazeutisch akzeptablen salze zur herstellung eines transplantation-immunitaet unterdrueckenden und anti-allergischen mittels.
ES2038799T3 (es) Derivados de 3-ciano-4-fenil-pirrol.
IE781644L (en) Benzimidazole-2-carbamate.
ES2039436T3 (es) Un procedimiento para preparar una composicion farmaceutica.
IT1245390B (it) Composizione farmaceutica ad attivita' antivirale
DK656389A (da) Phenyl-triazol-pyrimidin-derivat og dets anvendelse som laegemiddel
EP0154298A3 (de) Behandlung von Durchfall

Legal Events

Date Code Title Description
8364 No opposition during term of opposition